Ari joined GTCR in 2015 and became a Director in the Healthcare group in 2024. Previously, he worked as an Investment Analyst at Silver Point Capital and an Investment Banking Analyst at Morgan Stanley. Ari holds an MBA from Harvard Business School and a BA in mathematics and economics from Washington University in St. Louis, where he graduated summa cum laude and Phi Beta Kappa.

Ari works closely with Regatta Medical and TerSera Therapeutics. In addition, he was previously involved in GTCR investments in Antylia Scientific, Transaction Data Systems, AQUA Dermatology and Ceba-Tech.